Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells - PubMed (original) (raw)
. 2005 Feb 18;280(7):6157-69.
doi: 10.1074/jbc.M410491200. Epub 2004 Nov 29.
Affiliations
- PMID: 15572377
- DOI: 10.1074/jbc.M410491200
Free article
Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells
Bart S Hendriks et al. J Biol Chem. 2005.
Free article
Abstract
HER2, a member of the epidermal growth factor receptor (EGFR) tyrosine kinase family, functions as an accessory EGFR signaling component and alters EGFR trafficking by heterodimerization. HER2 overexpression leads to aberrant cell behavior including enhanced proliferation and motility. Here we applied a combination of computational modeling and quantitative experimental studies of the dynamic interactions between EGFR and HER2 and their downstream activation of ERK to understand this complex signaling system. Using cells expressing different levels of HER2 relative to the EGFR, we could separate relative contributions of EGFR and HER2 to signaling amplitude and duration. Based on our model calculations, we demonstrated that, in contrast with previous suggestions in the literature, the intrinsic capabilities of EGFR and HER2 to activate ERK were quantitatively equivalent. We found that HER2-mediated effects on EGFR dimerization and trafficking were sufficient to explain the observed HER2-mediated amplification of epidermal growth factor-induced ERK signaling. Our model suggests that transient amplification of ERK activity by HER2 arises predominantly from the 2-to-1 stoichiometry of receptor kinase to bound ligand in EGFR/HER2 heterodimers compared with the 1-to-1 stoichiometry of the EGFR homodimer, but alterations in receptor trafficking yielding increased EGFR sparing cause the sustained HER2-mediated enhancement of ERK signaling.
Similar articles
- A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD, Przypadlo CM, Buck A, Herbener N, Riedel B, Schäfer L, Nakagawa H, Walch A, Reinheckel T, Werner M, Lassmann S. Fichter CD, et al. J Pathol. 2017 Dec;243(4):481-495. doi: 10.1002/path.4987. Epub 2017 Nov 5. J Pathol. 2017. PMID: 28940194 Free PMC article. - Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels.
Hendriks BS, Opresko LK, Wiley HS, Lauffenburger D. Hendriks BS, et al. J Biol Chem. 2003 Jun 27;278(26):23343-51. doi: 10.1074/jbc.M300477200. Epub 2003 Apr 9. J Biol Chem. 2003. PMID: 12686539 - HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells.
Zhang Y, Opresko L, Shankaran H, Chrisler WB, Wiley HS, Resat H. Zhang Y, et al. BMC Cell Biol. 2009 Oct 31;10:78. doi: 10.1186/1471-2121-10-78. BMC Cell Biol. 2009. PMID: 19878579 Free PMC article. - Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
Earp HS, Dawson TL, Li X, Yu H. Earp HS, et al. Breast Cancer Res Treat. 1995 Jul;35(1):115-32. doi: 10.1007/BF00694752. Breast Cancer Res Treat. 1995. PMID: 7612898 Review. - Epidermal growth factor receptor dependence in human tumors: more than just expression?
Arteaga CL. Arteaga CL. Oncologist. 2002;7 Suppl 4:31-9. doi: 10.1634/theoncologist.7-suppl_4-31. Oncologist. 2002. PMID: 12202786 Review.
Cited by
- Target points in trastuzumab resistance.
Shojaei S, Gardaneh M, Rahimi Shamabadi A. Shojaei S, et al. Int J Breast Cancer. 2012;2012:761917. doi: 10.1155/2012/761917. Epub 2012 Feb 26. Int J Breast Cancer. 2012. PMID: 22482061 Free PMC article. - A mathematical model for the rational design of chimeric ligands in selective drug therapies.
Doldán-Martelli V, Guantes R, Míguez DG. Doldán-Martelli V, et al. CPT Pharmacometrics Syst Pharmacol. 2013 Feb 13;2(2):e26. doi: 10.1038/psp.2013.2. CPT Pharmacometrics Syst Pharmacol. 2013. PMID: 23887616 Free PMC article. - The role of the microenvironment in tumor growth and invasion.
Kim Y, Stolarska MA, Othmer HG. Kim Y, et al. Prog Biophys Mol Biol. 2011 Aug;106(2):353-79. doi: 10.1016/j.pbiomolbio.2011.06.006. Epub 2011 Jun 28. Prog Biophys Mol Biol. 2011. PMID: 21736894 Free PMC article. Review. - Cell surface receptors for signal transduction and ligand transport: a design principles study.
Shankaran H, Resat H, Wiley HS. Shankaran H, et al. PLoS Comput Biol. 2007 Jun;3(6):e101. doi: 10.1371/journal.pcbi.0030101. Epub 2007 Apr 20. PLoS Comput Biol. 2007. PMID: 17542642 Free PMC article. Review. - An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.
McLaughlin S, Smith SO, Hayman MJ, Murray D. McLaughlin S, et al. J Gen Physiol. 2005 Jul;126(1):41-53. doi: 10.1085/jgp.200509274. Epub 2005 Jun 13. J Gen Physiol. 2005. PMID: 15955874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous